These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38975633)

  • 1. Co-delivery of oncolytic virus and chemotherapeutic modality: Vincristine against prostate cancer treatment: A potent viro-chemotherapeutic approach.
    Anjum S; Naseer F; Ahmad T; Liaquat A; Abduh MS; Kousar K
    J Med Virol; 2024 Jul; 96(7):e29748. PubMed ID: 38975633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach.
    Naseer F; Ahmad T; Kousar K; Kakar S; Gul R; Anjum S; Shareef U
    Int J Nanomedicine; 2023; 18():185-205. PubMed ID: 36643861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
    Kousar K; Naseer F; Abduh MS; Anjum S; Ahmad T
    Front Immunol; 2023; 14():1175535. PubMed ID: 37283735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered measles virus as a novel oncolytic therapy against prostate cancer.
    Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E
    Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts.
    Radhakrishnan S; Miranda E; Ekblad M; Holford A; Pizarro MT; Lemoine NR; Halldén G
    Hum Gene Ther; 2010 Oct; 21(10):1311-25. PubMed ID: 20497039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier Cells for Delivery of Oncolytic Measles Virus into Tumors: Determinants of Efficient Loading.
    Xu C; Xia M; Meng G; Li C; Jiang A; Wei J
    Virol Sin; 2018 Jun; 33(3):234-240. PubMed ID: 29767404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
    Heinemann L; Simpson GR; Boxall A; Kottke T; Relph KL; Vile R; Melcher A; Prestwich R; Harrington KJ; Morgan R; Pandha HS
    BMC Cancer; 2011 Jun; 11():221. PubMed ID: 21645351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells.
    Tai CJ; Liu CH; Pan YC; Wong SH; Tai CJ; Richardson CD; Lin LT
    Sci Rep; 2019 May; 9(1):6767. PubMed ID: 31043633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
    Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
    BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
    Luo Y; Ling Y; Guo W; Pang J; Liu W; Fang Y; Wen X; Wei K; Gao X
    J Control Release; 2010 Oct; 147(2):278-88. PubMed ID: 20655966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1.
    Moehler M; Sieben M; Roth S; Springsguth F; Leuchs B; Zeidler M; Dinsart C; Rommelaere J; Galle PR
    BMC Cancer; 2011 Oct; 11():464. PubMed ID: 22029859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with an oncolytic adenovirus and antitumor activity of vincristine against retinoblastoma cells.
    Song X; Wang H; Jia R; Cun B; Zhao X; Zhou Y; Xu X; Qian G; Ge S; Fan X
    Int J Mol Sci; 2012; 13(9):10736-10749. PubMed ID: 23109819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
    Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
    Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities to debottleneck the downstream processing of the oncolytic measles virus.
    Loewe D; Dieken H; Grein TA; Weidner T; Salzig D; Czermak P
    Crit Rev Biotechnol; 2020 Mar; 40(2):247-264. PubMed ID: 31918573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Virus as a Novel Modality for the Treatment of Prostate Cancer.
    Lu M; Wei F; Ma S; Xu Z; Wang J; Yang C; Mao L
    Discov Med; 2021; 32(167):133-139. PubMed ID: 35220999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer.
    Thambiraj S; Vijayalakshmi R; Ravi Shankaran D
    Sci Rep; 2021 Feb; 11(1):2808. PubMed ID: 33531521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach [Retraction].
    Int J Nanomedicine; 2024; 19():5719-5720. PubMed ID: 38895151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent oncolytic activity of human enteroviruses against human prostate cancer.
    Berry LJ; Au GG; Barry RD; Shafren DR
    Prostate; 2008 May; 68(6):577-87. PubMed ID: 18288643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer.
    Mahira S; Kommineni N; Husain GM; Khan W
    Biomed Pharmacother; 2019 Feb; 110():803-817. PubMed ID: 30554119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic measles virus strains as novel anticancer agents.
    Msaouel P; Opyrchal M; Domingo Musibay E; Galanis E
    Expert Opin Biol Ther; 2013 Apr; 13(4):483-502. PubMed ID: 23289598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.